Radiobiologic principles in radionuclide therapy

Journal of Nuclear Medicine

Volumn 46, Issue 1 SUPPL., 2005, Pages

  Kassis, Amin I ^a   Adelstein, S James ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

particle emitters; particle emitters; Auger electron emitters; Radiobiology; Radionuclide therapy

Indexed keywords

DNA; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT;

ALPHA RADIATION; ARTICLE; BRACHYTHERAPY; BYSTANDER EFFECT; CANCER; CELL DEATH; CELL SURVIVAL; DNA DAMAGE; ELECTRON; ENERGY TRANSFER; EXTERNAL BEAM RADIOTHERAPY; HUMAN; IONIZATION; MOLECULAR CLONING; NONHUMAN; OXYGEN ENHANCEMENT RATIO; PARTICULATE MATTER; PHOTON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOBIOLOGY; RADIOISOTOPE THERAPY; ANIMAL; BIOLOGICAL MODEL; CELL FUNCTION; CHEMICAL MODEL; CHEMISTRY; HALF LIFE TIME; LINEAR ENERGY TRANSFER; METHODOLOGY; NEOPLASM; RADIATION DOSE; RADIATION EXPOSURE; RADIOTHERAPY; REVIEW;

ANIMALS; CELL PHYSIOLOGY; DNA; HALF-LIFE; HUMANS; LINEAR ENERGY TRANSFER; MODELS, BIOLOGICAL; MODELS, CHEMICAL; NEOPLASMS; RADIOBIOLOGY; RADIOISOTOPES; RADIOPHARMACEUTICALS; RADIOTHERAPY; RADIOTHERAPY DOSAGE;

EID: 14844359242     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Steele GG, ed. Basic Clinical Radiobiology. 2nd ed. London, UK: Arnold; 1997:1-254.
2. Walicka MA, Vaidyanathan G, Zalutsky MR, Adelstein SJ, Kassis AI. Survival and DNA damage in Chinese hamster V79 cells exposed to alpha particles emitted by DNA-incorporated astatine-211. Radiat Res. 1998;150:263-268.
3. Goddu SM, Howell RW, Rao DV. Cellular dosimetry: absorbed fractions for monoenergetic electron and alpha particle sources and S-values for radionuclides uniformly distributed in different cell compartments. J Nucl Med. 1994;35:303-316.
4. Cole A. Absorption of 20-eV to 50,000-eV electron beams in air and plastic. Radiat Res. 1969;38:7-33.
5. Sastry KSR, Howell RW, Rao DV, et al. Dosimetry of Auger emitters: physical and phenomenological approaches. In: Baverstock KF, Charlton DE, eds. DNA Damage by Auger Emitters. London, UK: Taylor and Francis; 1988:27-38.
6. Wright HA, Hamm RN, Turner JE, Howell RW, Rao DV, Sastry KSR. Calculations of physical and chemical reactions with DNA in aqueous solution from Auger cascades. Radiat Prot Dosim. 1990;31:59-62.
7. Kassis AI, Adelstein SJ, Haydock C, Sastry KSR, McElvany KD, Welch MJ. Lethality of Auger electrons from the decay of bromine-77 in the DNA of mammalian cells. Radiat Res. 1982;90:362-373.
8. 125IUdR in mammalian cells: implications of localized energy deposition by Auger processes. Radiat Res. 1987;109:78-89.
9. 131I radioimmunotherapy and fractionated external beam radiotherapy: comparative effectiveness in a human tumor xenograft. J Nucl Med. 1999;40:1764-1768.
10. Humm JL, Chin LM, Cobb L, Begent R. Microdosimetry in radioimmunotherapy. Radiat Prot Dosim. 1990;31:433-436.
11. International Commission on Radiation Units and Measurements. Absorbed-dose specification in nuclear medicine (ICRU Report 67). J ICRU. 2002;2:29.
12. Kocher DC. Radioactive Decay Data Tables: A Handbook of Decay Data for Application to Radiation Dosimetry and Radiological Assessments. Springfield, VA: National Technical Information Center, US Department of Energy; 1981:1-221.
13. International Commission on Radiation Units and Measurements. Stopping Powers and Ranges for Protons and Alpha Particles, Report 49. Bethesda, MD: International Commission on Radiation Units and Measurements; 1993:256.
14. Kassis AI, Harris CR, Adelstein SJ, Ruth TJ, Lambrecht R, Wolf AP. The in vitro radiobiology of astatine-211 decay. Radiat Res. 1986;105:27-36.
15. 212Bi distributed in the growth medium. Radiat Prot Dosim. 1994;52:311-315.
16. 90Y. Int J Radiat Oncol Biol Phys. 1984;10:341-348.
17. Macklis RM, Kinsey BM, Kassis AI, et al. Radioimmunotherapy with alpha-particle-emitting immunoconjugates. Science. 1988;240:1024-1026.
18. Zalutsky MR, McLendon RE, Garg PK, Archer GE, Schuster JM, Bigner DD. Radioimmunotherapy of neoplastic meningitis in rats using an alpha-particle-emitting immunoconjugate. Cancer Res. 1994;54:4719-4725.
19. McDevitt MR, Ma D, Lai LT, et al. Tumor therapy with targeted atomic nanogenerators. Science. 2001;294:1537-1540.
20. 3HTdR. Radiat Res. 1976;67:332-343.
21. 3H disintegration in the DNA of Chinese hamster cells. Curr Top Radiat Res Q. 1977;12:408-425.
22. International Commission on Radiation Units and Measurements. Stopping Powers for Electrons and Positrons, Report 37. Bethesda, MD: International Commission on Radiation Units and Measurements; 1984:1-271.
23. Esteban JM, Schlom J, Mornex F, Colcher D. Radioimmunotherapy of athymic mice bearing human colon carcinomas with monoclonal antibody B72.3: histological and autoradiographic study of effects on tumors and normal organs. Eur J Cancer Clin Oncol. 1987;23:643-655.
24. 131I-labeled monoclonal antibody CC49. Cancer Res. 1995;55(suppl):5881s-5887s.
25. Otte A, Mueller-Brand J, Dellas S, Nitzsche EU, Herrmann R, Maecke HR. Yttrium-90-labelled somatostatin-analogue for cancer treatment. Lancet. 1998;351:417-418.
26. 90Y-labeled anti-CD20 monoclonal antibody for treatment of nonHodgkin's lymphoma. Int J Oncol. 1999;15:1017-1025.
27. Axworthy DB, Reno JM, Hylarides MD, et al. Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity. Proc Natl Acad Sci USA. 2000;97:1802-1807.
28. 67Cu-2IT-BATLym-1 radioimmunoconjugate in mice implanted with human Burkitt's lymphoma (Raji). Clin Cancer Res. 1997;3:71-79.
29. 35S: theory and application to a cellular model. Radiat Res. 1980;84:407-425.
30. Kassis AI, Adelstein SJ, Haydock C, Sastry KSR. Thallium-201: an experimental and a theoretical radiobiological approach to dosimetry. J Nucl Med. 1983;24:1164-1175.
31. Charlton DE, Pomplun E, Booz J. Some consequences of the Auger effect: fluorescence yield, charge potential, and energy imparted. Radiat Res. 1987;111:553-564.
32. 123I: the use of the Auger effect as a biological probe at the nanometre level. Radiat Prot Dosim. 1990;31:333-338.
33. 131iodine. Radiat Res. 1971;47:94-109.
34. 125I-UdR in cultured mammalian cells. Curr Top Radiat Res Q. 1977;12:426-435.
35. 125I-labeled DNA-binding compound that induces double-stranded DNA breaks. Cancer Res. 1979;39:3244-3247.
36. Bloomer WD, McLaughlin WH, Weichselbaum RR, et al. Iodine-125-labelled tamoxifen is differentially cytotoxic to cells containing oestrogen receptors. Int J Radiat Biol. 1980;38:197-202.
37. 125I]iodoHoechst 33342: contribution of scavengeable effects. Int J Radiat Biol. 1999;75:1579-1587.
38. 3H: nuclear versus cytoplasmic radiation effects in murine L1210 leukaemia. Int J Radiat Biol. 1975;28:225-241.
39. 125I in mammalian cells. Radiat Res. 1987;111:305-318.
40. 125I-iododeoxyuridine as prototype for radionuclide therapy with Auger emitters. Nature. 1977;265:620-621.
41. 123I]iodo-2′-deoxyuridine in the radiotherapy of an early ascites tumor model. Int J Radiat Oncol Biol Phys. 1991;21:1541-1551.
42. 125I]iodo-2′-deoxyuridine. Acta Oncol. 2000;39:731-737.